The article reports that the Joint Advisory Committee (JAC) will issue the first of a series guidelines in October 2012 for an intentional oversight system on rinderpest. It states that JAC committee would approve all future studies on liver rinderpest virus to assure that its benefits balance the risks. It adds that the guidelines is still confidential, but includes laboratories from 20 countries including Africa, Middle East, and Asia.